Assyro AI

FDA Orange Book · active-ingredient family

Ceforanide

Ceforanide is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:PRECEF · NDA 050554

1

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
PRECEF×5BRISTOLNDA 050554May 24, 1984

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
PRECEF×5APOTHECONANDA 062579Nov 26, 1984

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ceforanide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.